The Journal of Organic Chemistry
Article
4.00 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 177.6, 163.9, 158.6,
152.4, 145.1, 139.2, 123.2, 113.0, 111.8, 110.6, 53.4.
eV) m/z (%) 234 (767) [M+], 205 (23), 189 (25), 175 (68), 162
(100), 133 (31), 105 (22).
2-(5-(3,4,5-Trimethoxyphenyl)furan-2-yl)-1,3-dioxolane 4c. Fol-
5-(5-Fluoropyridin-2-yl)furan-2-carbaldehyde 3e. Following the
general procedure, 0.46 g of 3e was obtained as an off-white solid in
lowing the general procedure, 0.67 g of 4c was obtained as a yellow
1
1
solid in 73% isolated yield: mp 104−105 °C; H NMR (CDCl3, 300
60% isolated yield: mp 107−108 °C; H NMR (CDCl3, 500 MHz) δ
MHz) δ 6.89 (s, 2H), 6.53 (q, J = 3.0 Hz, 2H), 6.00 (s, 1H), 4.15 (m,
2H), 4.05 (m, 2H), 3.91 (s, 9H); 13C NMR (CDCl3, 75 MHz) δ
154.6, 153.7, 150.7, 138.2, 126.4, 110.7, 105.3, 101.7, 98.1, 65.3, 61.1,
56.4; HRMS (EI) for [C16H18O6] calcd 306.1103, found 306.1108.
2-(5-(2,3,5,6-Tetramethylphenyl)furan-2-yl)-1,3-dioxolane 4d.
Following the general procedure, 0.52 g of 4d was obtained as a
white solid in 64% isolated yield: mp 117−118 °C; 1H NMR (CDCl3,
300 MHz) δ 7.01 (s, 1H), 6.54 (d, J = 3.0 Hz, 1H), 6.19 (d, J = 3.0 Hz,
1H), 5.96 (s, 1H), 4.16−4.12 (m, 2H), 4.02−3.98 (m, 2H), 2.23 (s,
6H), 2.02 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 154.2, 150.4, 134.9,
133.8, 132.4, 131.2, 109.8, 109.5, 98.2, 65.3, 20.2, 17.1; HRMS (EI) for
[C17H20O3] calcd 272.1412, found 272.1410.
2-(5-(4-tert-Butylphenyl)furan-2-yl)-1,3-dioxolane 4e. Following
the general procedure, 0.67 g of 4e was obtained as a light orange oil in
82% isolated yield: 1H NMR (CDCl3, 500 MHz) δ 7.60 (d, J = 10 Hz,
2H), 7.39 (d, J = 10 Hz, 2H), 6.55 (d, J = 5.0 Hz, 1H), 6.50 (d, J = 5.0
Hz, 1H), 5.99 (s, 1H), 4.17−4.13 (m, 2H), 4.0−4.01 (m, 2H), 1.34 (s,
9H); 13C NMR (CDCl3, 125 MHz) δ 154.9, 150.9, 150.5, 128.0,
125.7, 124.0, 110.6, 105.0, 98.1, 65.3, 34.8, 31.4; GC−MS (EI, 70 eV)
m/z (%) 272 (100) [M+], 257 (100), 227 (16), 213 (55), 185 (63),
157 (16), 115 (17), 73 (22).
9.72 (s, 1H), 8.52 (d, J = 2.5 Hz, 1H), 7.97−7.95 (m, 1H), 7.5−7.51
(m, 1H), 7.36 (d, J = 3.5 Hz, 1H), 7.20 (d, J = 3.5 Hz, 1H); 13C NMR
(CDCl3, 125 MHz) δ 177.6, 160.3, 158.2, 157.5, 152.5, 144.2, 138.5,
123.6, 123.3, 121.3, 110.5; HRMS (EI) for [C10H6NO2F] calcd
191.0383, found 191.0389.
5-(Pyridin-3-yl)furan-2-carbaldehyde 3f. Following the general
procedure, 1.18 g of 3f was obtained as an off-white solid in 85%
1
isolated yield: mp 100−101 °C; H NMR (CDCl3, 500 MHz) δ 9.72
(s, 1H), 9.06 (s, 1H), 8.64−8.63 (m, 1H), 8.12 (d, J = 8.0 Hz, 1H),
7.42−7.40 (m, 1H), 7.36 (d, J = 3.5 Hz, 1H), 6.96 (d, J = 3.5 Hz, 1H);
13C NMR (CDCl3, 125 MHz) δ 177.4, 156.3, 152.6, 150.3, 146.7,
132.2, 125.2, 123.8, 123.1, 108.8; GC−MS (EI, 70 eV) m/z (%) 173
(100) [M+], 145 (7), 116 (51), 89 (26), 63 (32).
5-(6-Chloropyridin-3-yl)furan-2-carbaldehyde 3g. Following the
general procedure, 0.79 g of 3g was obtained as a beige solid in 95%
1
isolated yield: mp 169−170 °C; H NMR (CDCl3, 500 MHz) δ 9.72
(s, 1H), 8.84 (s, 1H), 8.10 (dd, J = 2.5 Hz, 1H), 7.45 (d, J = 8.5 Hz,
1H), 7.36 (d, J = 3.5 Hz, 1H), 6.96 (d, J = 3.5 Hz, 1H) ; 13C NMR
(CDCl3, 125 MHz) δ 177.4, 155.1, 152.8, 152.1, 146.4, 134.9, 124.7,
124.3, 123.0, 109.2; GC−MS (EI, 70 eV) m/z (%) 207 (100) [M+],
179 (9), 150 (47), 115 (15), 63 (18).
2-(5-(1,2-Dihydroacenaphthylen-6-yl)furan-2-yl)-1,3-dioxolane
5-(2-Chloropyridin-3-yl)furan-2-carbaldehyde 3h. Following the
general procedure, 0.61 g of 3h was obtained as a white solid in 72%
4f. Following the general procedure, 0.82 g of 4f was obtained as a
1
light brown oil in 93% isolated yield: H NMR (CDCl3, 500 MHz) δ
1
isolated yield: mp 103−104 °C; H NMR (CDCl3, 500 MHz) δ 9.74
8.11 (d, J = 10 Hz, 1H), 7.75 (d, J = 10 Hz, 1H), 7.50−7.47 (m, 1H),
7.30−7.27 (m, 2H), 6.68 (d, J = 5.0 Hz, 1H), 6.59 (d, J = 5.0 Hz, 1H),
6.05 (s, 1H), 4.20−4.15 (m, 2H), 4.05−4.00 (m, 2H), 3.39−3.35 (m,
4H); 13C NMR (CDCl3, 125 MHz) δ 154.6, 150.6, 146.9, 146.5,
139.8, 128.8, 128.4, 127.3, 123.8, 121.0, 119.8, 119.2, 110.5, 108.3,
98.2, 65.4, 30.6, 30.3; GC−MS (EI, 70 eV) m/z (%) 292 (100) [M+],
248 (15), 233 (70), 220 (45), 189 (25), 152 (16).
3-(5-(1,3-Dioxolan-2-yl)furan-2-yl)-N,N-dimethylbenzenamine
4g. Following the general procedure, 0.71 g of 4g was obtained as a
yellow oil in 92% isolated yield: 1H NMR (CDCl3, 500 MHz) δ 7.24−
7.06(m, 3H), 6.69(br s, 1H), 6.59(d, J = 5.0 Hz, 1H), 6.50 (d, J = 5.0
Hz, 1H),6.01 (s, 1H), 4.18−4.14 (m, 2H), 4.06−4.03 (m, 2H), 3.02
(s,6H); GC−MS (EI, 70 eV) m/z (%) 259 (100) [M+], 228 (5), 214
(19), 200 (54), 187 (30).
(s, 1H), 8.45−8.43 (m, 1H), 8.39 (dd, J = 2.0 Hz, 1H), 7.47 (d, J = 4.0
Hz, 1H), 7.43−7.41 (m, 1H), 7.40 (d, J = 4.0 Hz, 1H); 13C NMR
(CDCl3, 125 MHz) δ 177.5, 153.1, 152.3, 149.3, 147.7, 137.3, 124.9,
122.8, 114.2.
5-(2-Chloropyridin-4-yl)furan-2-carbaldehyde 3i. Following the
general procedure, 0.55 g of 3i was obtained as an off-white solid in
1
66% isolated yield: mp 115−116 °C; H NMR (CDCl3, 500 MHz) δ
9.77 (s, 1H), 8.49 (d, J = 5.5 Hz, 1H), 7.73 (s, 1H), 7.60 (d, J = 5.5
Hz, 1H), 7.37 (d, J = 3.5 Hz, 1H), 7.10 (d, J = 3.5 Hz, 1H); 13C NMR
(CDCl3, 125 MHz) δ 177.7, 154.5, 153.1, 152.7, 150.5, 138.6, 122.2,
119.4, 117.6, 111.5; GC−MS (EI, 70 eV) m/z (%) 207 (100) [M+],
179 (5), 150 (31), 115 (10), 89 (17), 63 (19).
Preparation of 5-(1,3-Dioxolan-2-yl)-2-furanylzinc Bromide. In an
oven-dried 50 mL round-bottomed flask equipped with a stir bar was
added 0.93 g of active zinc (Zn*, 14.25 mmol). 2-(5-Bromofuran-2-
yl)-1,3-dioxolane (2.08 g, 9.5 mmol) was then cannulated neat into the
flask at room temperature. The resulting mixture was stirred at room
temperature for 3 h. The whole mixture was allowed to settle, and then
the supernatant was used for the subsequent coupling reactions.
Ethyl 5-(5-(1,3-Dioxolan-2-yl)furan-2-yl)furan-2-carboxylate 4b.
In a 25 mL round-bottomed flask was added Pd[P(Ph3)]4 (0.06 g, 1
mol %) under an argon atmosphere, and then 10 mL of 5-(1,3-
dioxolan-2-yl)-2-furanylzinc bromide (0.5 M in THF, 5.0 mmol) was
added via a syringe. Next, ethyl 5-bromofuran-2-carboxylate (0.88 g,
4.0 mmol) was added into the flask. The resulting mixture was stirred
at room temperature overnight, quenched with saturated NH4Cl
solution, and then extracted with ethyl ether (10 mL × 3). Washed
with saturated Na2S2O3 solution and brine, then dried over anhydrous
MgSO4. Purification by column chromatography on silica gel (10%
ethyl acetate/90% heptane) afforded ethyl 5-(5-(1,3-dioxolan-2-
yl)furan-2-yl)furan-2-carboxylate (4b, 0.70 g) in 63% isolated yield
as a light yellow viscous oil; 1H NMR (CDCl3, 500 MHz) δ 7.21 (d, J
= 5.0 Hz, 1 H), 6.77 (d, J = 5.0 Hz, 1 H), 6.67 (d, J = 5.0 Hz, 1 H),
6.53 (d, J = 5.0 Hz, 1 H), 5.97 (s, 1 H), 4.37 (q, J = 5.0 Hz, 2 H), 4.13
(m, 2 H), 4.04 (m, 2 H), 1.38 (t, J = 5.0 Hz, 3 H); 13C NMR (CDCl3,
125 MHz) δ 158.8, 152.0, 149.4, 145.9, 143.9, 119.7, 110.7, 108.6,
107.4, 97.7, 65.4, 61.1, 14.5; GC−MS (EI, 70 eV) m/z (%) 259 (100)
[M+], 214 (20), 200 (53), 187 (30).
4-(5-(1,3-Dioxolan-2-yl)furan-2-yl)phenol 5a. In a 25 mL round-
bottomed flask, Pd(OAc)2 (0.02 g, 2.0 mol %), SPhos (0.08 g, 4.0 mol
%) and THF (5 mL) were placed. Next, 5-(1,3-dioxolan-2-yl)-2-
furanylzinc bromide (0.5 M in THF, 10 mL) was added slowly. After
being stirred for 1 h at room temperature, quenched with saturated
NH4Cl solution, then extracted with ethyl acetate (10 mL × 3), which
was washed with saturated Na2S2O3 solution and brine and then dried
over anhydrous MgSO4. Purification by column chromatography on
silica gel (20% ethyl acetate/80% heptane) afforded 4-(5-(1,3-
Dioxolan-2-yl)furan-2-yl)phenol (5a, 0.85 g) as a beige solid in 92%
1
isolated yield; mp 150−152 °C; H NMR (CDCl3, 500 MHz) δ 7.54
(d, J = 10.0 Hz, 2 H), 6.83 (d, J = 10.0 Hz, 2 H), 6.50 (d, J = 5.0 Hz, 1
H), 6.45 (d, J = 5.0 Hz, 1 H), 5.99 (s, 1 H), 5.20 (br s, 1 H), 4.18 (t, J
= 5.0 Hz, 2 H), 4.05 (t, J = 5.0 Hz, 2 H); 13C NMR (CDCl3, 125
MHz) δ 155.5, 154.9, 149.9, 125.9, 115.77, 110.9, 104.0, 98.1, 65.6;
GC−MS (EI, 70 eV) m/z (%) 232 (100) [M+], 187 (22), 173 (100),
160 (58), 131 (42), 73 (41).
3-(5-(1,3-Dioxolan-2-yl)furan-2-yl)phenol 5b. Following the gen-
eral procedure; the formation of the desired product was confirmed by
GC−MS (EI, 70 eV) m/z (%) 232 (100) [M+], 187 (43), 173 (99),
160 (86), 131 (57), 73 (80).
2-(5-(1,3-Dioxolan-2-yl)furan-2-yl)phenol 5c. The conversion to
the corresponding product was confirmed by GC.
4-(5-(1,3-Dioxolan-2-yl)furan-2-yl)benzenamine 5d. The forma-
tion of the desired product was confirmed by GC−MS (EI, 70 eV) m/
z (%) 231 (100) [M+], 200 (6), 187 (14), 172 (95), 159 (34), 130
(33).
5-(5-(1,3-Dioxolan-2-yl)furan-2-yl)furan-2-carbaldehyde 4a. The
formation of the desired product was confirmed by GC−MS (EI, 70
1991
dx.doi.org/10.1021/jo301836x | J. Org. Chem. 2013, 78, 1984−1993